Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.78% | 42.00 | 0.9% | $967.82m | |
| MRK | Merck & Co., Inc. | 1.86% | 80.98 | 0.6% | $797.52m | |
| JNJ | Johnson & Johnson | 0.46% | 138.76 | 0.7% | $772.80m | |
| BMY | Bristol-Myers Squibb Company | 0.64% | 47.74 | 1.4% | $659.03m | |
| LLY | Eli Lilly and Company | 1.20% | 117.98 | 1.0% | $500.32m | |
| ABBV | AbbVie, Inc. | 0.90% | 81.61 | 2.2% | $449.20m | |
| AZN | AstraZeneca PLC Sponsored ADR | 2.01% | 38.64 | 1.3% | $190.16m | |
| NVS | Novartis AG Sponsored ADR | 1.88% | 83.94 | 0.2% | $190.02m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | 2.03% | 40.19 | 0.2% | $102.66m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | 1.84% | 48.41 | 0.1% | $64.13m | |
| SNY | Sanofi Sponsored ADR | 2.21% | 42.09 | 0.2% | $48.51m | |
| LCI | Lannett Company, Inc. | -1.14% | 6.06 | 36.7% | $10.02m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | -4.74% | 2.41 | 1.6% | $3.40m | |
| EPIX | ESSA Pharma Inc | -6.51% | 2.01 | 0.1% | $0.01m |
Company Profile
Nightstar Therapeutics plc is a clinical-stage gene therapy holding company, which engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. Its pipeline includes NSR-REP1, for the treatment of choroideremia; NSR-RPGR, for the treatment of X-linked retinitis pigmentosa; and NSR-BEST1, for the treatment of vitelliform macular dystrophy. The company was founded by Robert MacLaren on July 6, 2017 and is headquartered in London, the United Kingdom.